Clinical Trial: A Study to Investigate the Response of Participants With Type 2 Diabetes Mellitus on Once-Weekly Retatrutide to Hypoglycemia

U.S., May 22 -- ClinicalTrials.gov registry received information related to the study (NCT06982846) titled 'A Study to Investigate the Response of Participants With Type 2 Diabetes Mellitus on Once-Weekly Retatrutide to Hypoglycemia' on May 14.

Brief Summary: The purpose of this study is to measure the effect of retatrutide versus placebo, administered every week, on time to recovery from hypoglycemia during hypoglycemic clamp in participants with Type 2 Diabetes Mellitus (T2DM) following 16 weeks of treatment.

Study Start Date: June, 2025

Study Type: INTERVENTIONAL

Condition: Type 2 Diabetes Mellitus

Intervention: DRUG: Retatrutide

Administered SC

DRUG: Placebo

Administered SC

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Eli...